Astrazeneca tops expectations in the first quarter on strong cancer drug sales

CAMBRIDGE, Britain (AP) — Astrazeneca on Wednesday reported first-quarter profit of $3.08 billion. The Cambridge, Britain-based company said it had net income of 99 cents per share. Earnings, adjusted for non-recurring costs, were $2.58 per share. The results beat Wall Street expectations. The ave...

Redirecting to full article...